$27.380
+2.054 (+7.50%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VKTX Prediction & Forecast by Similar Chart Analysis
Alphio's VKTX stock price prediction model matches the current Viking Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.65 (+4.67%). The 1-week path is $29.87 (+9.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Viking Therapeutics Inc Stock?
Viking Therapeutics is a good buy right now due to its current price of $28.51, which is significantly lower than the average analyst price target of $102, indicating a potential upside of over 250%. Additionally, the company has raised $575 million to fund its promising weight-loss drug VK2735, which is projected to capture a substantial share of the $200 billion obesity drug market by 2030. However, the main risk is the negative earnings trend, with a projected EPS of -1.10 for Q2 2026, which could impact investor sentiment if not addressed.
VKTX stock price ended at $27.38 on Thursday, after rising +7.50%
Viking Therapeutics Inc (VKTX) last closed at $27.37, gaining +7.46%. These facts feed the 1-day and 1-week VKTX price prediction above.
Analyst Consensus
Viking Therapeutics Inc (VKTX): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Viking Therapeutics Inc (VKTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches VKTX, ranked by similarity.
Seasonality analysis for VKTX
Historically the probability of a positive October return for VKTX is 40.35%. July offers the highest probability of a positive month at 56.06%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VKTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $34.27 | $38.65 | $45.92 | +41.22% |
| Nov 2026 | $28.76 | $35.24 | $38.15 | +28.76% |
| Dec 2026 | $28.47 | $28.57 | $29.25 | +4.38% |
In 2026, Viking Therapeutics Inc (VKTX) is projected to range from $28.47 to $45.92.
Viking Therapeutics Inc 2026 monthly forecast
In Oct 2026, Viking Therapeutics Inc is projected to average $38.65, with a low of $34.27 and high of $45.92.
In Nov 2026, Viking Therapeutics Inc is projected to average $35.24, with a low of $28.76 and high of $38.15.
In Dec 2026, Viking Therapeutics Inc is projected to average $28.57, with a low of $28.47 and high of $29.25.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.